| Financial Year |
March 31 2023 |
| Monetary Funds |
234,685,063.98 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
118,667,780.78 |
| Advances to Suppliers |
10,813,998.67 |
| Other Receivables |
6,315,474.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
287,796,829.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
39,762,863.45 |
| Total Current Assets |
698,042,011.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
10,727,189.46 |
| Investment Properties |
-- |
| Fixed Assetes |
409,481,739.82 |
| Under-construction Projects |
321,556,018.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
67,284,848.51 |
| R&D expenses |
-- |
| Goodwill |
51,690,718.24 |
| Long-Term Deferred and Prepaid Expenses |
13,918,138.93 |
| Deferred Income Tax Assets |
28,285,259.70 |
| Other Non-Current Assets |
25,295,455.77 |
| Sub-Total of Non-Current Assets |
960,937,390.28 |
| Total Assets |
1,658,979,401.59 |
| Short-Term Loans |
77,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
100,930,000.00 |
| Accounts Payable |
246,758,054.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,178,740.02 |
| Taxes Payable |
15,152,383.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,336,814.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,161,744.48 |
| Other Current Liabilities |
34,305,954.27 |
| Sub-Total of Current Liabilities |
533,328,928.26 |
| Long-term Loans |
197,304,246.73 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,144,761.64 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
253,038,377.90 |
| Total Liabilities |
786,367,306.16 |
| Paid-In Capital(Or Share Stock) |
480,760,000.00 |
| Capital Surplus |
102,219,813.45 |
| Surplus Reserve |
37,306,143.64 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
233,049,658.20 |
| Minority Stockholder's Interest |
19,267,845.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
853,344,250.01 |
| Owner's Equity（Stockholder's Equity） |
872,612,095.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,658,979,401.59 |
